Vilija Jokubaitis

Immunoregulatory effects and therapeutic potential of Vitamin D in multiple sclerosis.

Wei Zhen Yeh, Melissa Gresle, Vilija Jokubaitis, Jim Stankovich, Anneke van der Walt, Helmut Butzkueven

Journal article  |  2020  |  British Journal of Pharmacology

Initially recognised as an important factor for bone health, Vitamin D is now known to have a range of effects on the immune syste..

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

Amy Kunchok, Jeannette Lechner-Scott, Franco Granella, Maria Trojano, Raed Alroughani, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Marco Onofrj, Serkan Ozakbas, Guillermo Izquierdo, Pierre Grammond, Jose Luis Sanchez-Menoyo, Bart Van Wijmeersch, Cavit Boz, Eugenio Pucci, Pamela McCombe, Francois Grand'Maison, Daniele Spitaleri, Steve Vucic, et al.

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) score combines relapses and magnetic resonance imaging ..

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells.

Melissa M Gresle, Margaret A Jordan, Jim Stankovich, Tim Spelman, Laura J Johnson, Louise Laverick, Alison Hamlett, Letitia D Smith, Vilija G Jokubaitis, Josephine Baker, Jodi Haartsen, Bruce Taylor, Jac Charlesworth, Melanie Bahlo, Terence P Speed, Matthew A Brown, Judith Field, Alan G Baxter, Helmut Butzkueven

Journal article  |  2020  |  Life Science Alliance

At least 200 single-nucleotide polymorphisms (SNPs) are associated with multiple sclerosis (MS) risk. A key function that could me..

MSCOVID19: Using social media to achieve rapid dissemination of health information.

Cassie Nesbitt, Louise Rath, Wei Zhen Yeh, Michael Zhong, Robb Wesselingh, Mastura Monif, Janene Richards, Viet Bui Minh, Vilija G Jokubaitis, Olga Skibina, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND AND OBJECTIVE: The global COVID-19 pandemic creates an obvious acute health care resourcing and response problem. The d..

Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study

Emma Foster, Michael J Malloy, Vilija G Jokubaitis, C David H Wrede, Helmut Butzkueven, Joe Sasadeusz, Sharon Van Doornum, Finlay Macrae, Gary Unglik, Julia ML Brotherton, Anneke van der Walt

Journal article  |  2020  |  PLOS ONE

BACKGROUND: Autoimmune conditions (AICs) and/or their treatment may alter risk of human papilloma virus (HPV) infection and female..

Sex effects across the lifespan in women with multiple sclerosis

Kristen M Krysko, Jennifer S Graves, Ruth Dobson, Ayse Altintas, Maria Pia Amato, Jacqueline Bernard, Simona Bonavita, Riley Bove, Paola Cavalla, Marinella Clerico, Teresa Corona, Anisha Doshi, Yara Fragoso, Dina Jacobs, Vilija Jokubaitis, Doriana Landi, Gloria Llamosa, Erin E Longbrake, Elisabeth Maillart, Monica Marta, et al.

Journal article  |  2020  |  Therapeutic Advances in Neurological Disorders

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating central nervous system disorder that is more common in women, ..

Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis.

Ruth Dobson, Vilija G Jokubaitis, Gavin Giovannoni

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND: Women with MS are advised that relapse rates fall during pregnancy and rebound post-partum. This advice originates fro..

OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas

Frederique MC Boonstra, Andrew Evans, Gustavo Noffs, Thushara Perera, Vilija Jokubaitis, Jim Stankovich, Adam P Vogel, Bradford A Moffat, Helmut Butzkueven, Scott C Kolbe, Anneke van der Walt

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND: Treatment of tremor in MS is an unmet need. OnabotulinumtoxinA (BoNT-A) has shown promising results; however, little i..

Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis.

Frederique Mc Boonstra, Gustavo Noffs, Thushara Perera, Vilija G Jokubaitis, Adam P Vogel, Bradford A Moffat, Helmut Butzkueven, Andrew Evans, Anneke van der Walt, Scott C Kolbe

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: Tremor is present in almost half of multiple sclerosis (MS) patients. The lack of understanding of its pathophysiology..

Family planning is the second most relevant factor for treatment decisions after disease activity - Commentary.

Vilija G Jokubaitis, Ruth Dobson

Journal article  |  2020  |  Multiple Sclerosis Journal

Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.

Vilija G Jokubaitis, Ruth Dobson

Journal article  |  2020  |  Neurology

Pregnancy and multiple sclerosis: Clinical effects across the lifespan

Nguyen Ai-Lan, Alana Eastaugh, Anneke van der Walt, Vilija G Jokubaitis

Journal article  |  2019  |  Autoimmunity Reviews

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolas A Patsopoulos, Sergio E Baranzini, Adams Santaniello, Parisa Shoostari, Chris Cotsapas, Garrett Wong, Ashley H Beecham, Tojo James, Joseph Replogle, Ioannis S Vlachos, Cristin McCabe, Tune H Pers, Aaron Brandes, Charles White, Brendan Keenan, Maria Cimpean, Phoebe Winn, Ioannis-Pavlos Panteliadis, Allison Robbins, Till FM Andlauer, et al.

Journal article  |  2019  |  Science

Family planning, antenatal and post partum care in multiple sclerosis: a review and update

Anneke Van Der Walt, Nguyen Ai-Lan, Vilija Jokubaitis

Journal article  |  2019  |  Medical Journal of Australia

Multiple sclerosis is more prevalent in women of childbearing age than in any other group. As a result, the impact of multiple scl..

Risk of secondary progressive multiple sclerosis: A longitudinal study

Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Raymond Hupperts, Cavit Boz, Jeannette Lechner-Scott, Eugenio Pucci, et al.

Journal article  |  2019  |  Multiple Sclerosis Journal

Introducing the International Women in Multiple Sclerosis network

Vilija G Jokubaitis, Anne-Katrin Probstel, Georgina Arrambide, Fiona Costello, Emmanuelle Waubant

Journal article  |  2019  |  The Lancet Neurology

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Tomas Kalincik, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Marco Onofrj, Alessandra Lugaresi, Serkan Ozakbas, Ludwig Kappos, Jens Kuhle, Murat Terzi, Jeannette Lechner-Scott, Cavit Boz, Francois Grand'Maison, Julie Prevost, Patrizia Sola, Diana Ferraro, et al.

Journal article  |  2019  |  Journal of Neurology, Neurosurgery & Psychiatry

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Ai-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Tomas Kalincik, Anneke van der Walt, Murat Terzi, Raed Alroughani, Pierre Duquette, Marc Girard, Alexandre Prat, Cavit Boz, Patrizia Sola, Diana Ferrara, Alessandra Lugaresi, Jeannette Lechner-Scott, Michael Barnett, Francois Grand'Maison, Pierre Grammond, Cristina Ramo-Tello, et al.

Journal article  |  2019  |  Multiple Sclerosis and Related Disorders

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, Francois Grand'Maison, Murat Terzi, et al.

Journal article  |  2019  |  JAMA

Gender Inequities in the Multiple Sclerosis Community: A Call for Action

Emmanuelle Waubant, Lilyana Amezcua, Nancy Sicotte, Kerstin Hellwig, Lauren Krupp, Bianca Weinstock-Guttman, Ann Yeh, Robyn M Lucas, Erin E Longbrake, Vijay Yadav, Mary Rensel, Soe Mar, Carrie Hersh, Valerie Block, Frauke Zipp, May H Han, Rebecca Spain, Eve E Kelland, Leigh Charvet, Dalia Dimitri, et al.

Journal article  |  2018  |  Annals of Neurology

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

Jordana Hughes, Vilija Jokubaitis, Alessandra Lugaresi, Raymond Hupperts, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Cristina Ramo-Tello, Maria Trojan, Mark Slee, Vahid Shaygannejad, Cavit Boz, Jeanette Lechner-Scott, Vincent Van Pesch, Eugenio Pucci, et al.

Journal article  |  2018  |  JAMA Neurology

Cladribine versus fingolimod, natalizumab and interferon for multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Jeannette Lechner-Scott, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Claudio Solaro, Francois Grand'Maison, Raymond Hupperts, Julie Prevost, Patrizia Sola, Diana Ferraro, Murat Terzi, Ernest Butler, et al.

Journal article  |  2018  |  MULTIPLE SCLEROSIS JOURNAL

Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction?

Vilija G Jokubaitis, Yuan Zhou, Helmut Butzkueven, Bruce V Taylor

Journal article  |  2018  |  Current Treatment Options in Neurology

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Alessio Signori, Guillermo Izquierdo, Alessandra Lugaresi, Raymond Hupperts, Francois Grand'Maison, Patrizia Sola, Dana Horakova, Eva Havrdova, Alexandre Prat, Marc Girard, Pierre Duquette, Cavit Boz, Pierre Grammond, Murat Terzi, Bhim Singhal, Raed Alroughani, Thor Petersen, Cristina Ramo, Celia Oreja-Guevara, Daniele Spitaleri, et al.

Journal article  |  2018  |  MULTIPLE SCLEROSIS JOURNAL

Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis (vol 23, pg 596, 2017)

T Kalincik, V Jokubaitis, T Spelman

Journal article  |  2017  |  Multiple Sclerosis Journal

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Johannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, Guillermo Izquierdo, Alessandra Lugaresi, Eva Havrdova, Dana Horakova, Maria Trojano, Pierre Duquette, Marc Girard, Alexandre Prat, Francois Grand'Maison, Pierre Grammond, Eugenio Pucci, Cavit Boz, Patrizia Sola, Diana Ferraro, Daniele Spitaleri, Jeanette Lechner-Scott, Murat Terzi, et al.

Journal article  |  2017  |  NEUROLOGY

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Tim Spelman, Claire Meyniel, Juan Ignacio Rojas, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Cavit Boz, Raed Alroughani, Eva Havrdova, Dana Horakova, Gerardo Iuliano, Pierre Duquette, Murat Terzi, Pierre Grammond, Raymond Hupperts, Jeannette Lechner-Scott, Celia Oreja-Guevara, Eugenio Pucci, Freek Verheul, Marcela Fiol, et al.

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Tomas Kalincik, Ali Manouchehrinia, Lukas Sobisek, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Marc Girard, Alexandre Prat, Pierre Duquette, Pierre Grammond, Patrizia Sola, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Cavit Boz, Raed Alroughani, et al.

Journal article  |  2017  |  BRAIN

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

S Mahurkar, M Moldovan, V Suppiah, M Sorosina, F Clarelli, G Liberatore, S Malhotra, X Montalban, A Antiguedad, M Krupa, VG Jokubaitis, FC Mckay, PN Gatt, MJ Fabis-Pedrini, V Martinelli, G Comi, J Lechner-Scott, AG Kermode, M Slee, BV Taylor, et al.

Journal article  |  2017  |  The Pharmacogenomics Journal

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomas Kalincik, J William L Brown, Neil Robertson, Mark Willis, Neil Scolding, Claire M Rice, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Christopher McGuigan, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, et al.

Journal article  |  2017  |  LANCET NEUROLOGY

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Nathaniel Lizak, Alessandra Lugaresi, Raed Alroughani, Jeannette Lechner-Scott, Mark Slee, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Alexandre Prat, Pierre Grammond, Raymond Hupperts, Francois Grand'Maison, Patrizia Sola, Eugenio Pucci, Roberto Bergamaschi, Celia Oreja-Guevara, Vincent Van Pesch, et al.

Journal article  |  2017  |  JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Contribution of different relapse phenotypes to disability in multiple sclerosis

Tamasine Stewart, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Vahid Shaygannejad, Raymond Hupperts, Raed Alroughani, Celia Oreja-Guevara, Eugenio Pucci, Cavit Boz, Jeannette Lechner-Scott, et al.

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

A genetic basis for multiple sclerosis severity: Red herring or real?

Vilija G Jokubaitis, Helmut Butzkueven

Journal article  |  2016  |  Molecular and Cellular Probes

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

N Lizak, A Lugaresi, R Alroughani, J Lechner-Scott, M Slee, E Havrdova, D Horakova, M Trojano, G Izquierdo, P Duquette, M Girard, A Prat, P Grammond, R Hupperts, FG Maison, P Sola, E Pucci, R Bergamaschi, C Oreja-Guevara, VV Pesch, et al.

Journal article  |  2016  |  Journal of Neurology, Neurosurgery and Psychiatry

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Raymond Hupperts, Raed Alroughani, Patrizia Sola, Cavit Boz, Eugenio Pucci, Jeanette Lechner-Scott, et al.

Journal article  |  2016  |  BRAIN

Anti-inflammatory disease modifying treatment does not attenuate disability progression in secondary progressive multiple sclerosis

J Lorscheider, V Jokubaitis, T Spelman, G Izquierdo, A Lugaresi, E Havrdova, D Horakova, M Trojano, P Duquette, M Girard, A Prat, F Grand'Maison, R Hupperts, P Grammond, E Pucci, C Boz, P Sola, D Spitaleri, J Lechner-Scott, M Terzi, et al.

Conference Proceedings  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Pregnancy protects against long-term disability accrual in relapsing-remitting MS

VG Jokubaitis, T Kalincik, J Lorscheider, T Spelman, D Horakova, P Duquette, M Girard, A Prat, G Izquierdo, P Grammond, E Pucci, F Grand'Maison, F Granella, P Sola, R Bergamaschi, G Iuliano, D Spitaleri, S Hodgkinson, J Olascoaga, F Verheul, et al.

Conference Proceedings  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis

Vilija G Jokubaitis, Tim Spelman, Tomas Kalincik, Johannes Lorscheider, Eva Havrdova, Dana Horakova, Pierre Duquette, Marc Girard, Alexandre Prat, Guillermo Izquierdo, Pierre Grammond, Vincent Van Pesch, Eugenio Pucci, Francois Grand'Maison, Raymond Hupperts, Franco Granella, Patrizia Sola, Roberto Bergamaschi, Gerardo Iuliano, Daniele Spitaleri, et al.

Journal article  |  2016  |  Annals of Neurology

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Matthew Warrender-Sparkes, Tim Spelman, Guillermo Izquierdo, Maria Trojano, Alessandra Lugaresi, Francois Grand'Maison, Eva Havrdova, Dana Horakova, Cavit Boz, Celia Oreja-Guevara, Raed Alroughani, Gerardo Iuliano, Pierre Duquette, Marc Girard, Murat Terzi, Raymond Hupperts, Pierre Grammond, Thor Petersen, Ricardo Fernandez-Bolanos, Marcela Fiol, et al.

Journal article  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Comparative efficacy of first-line natalizumab vs IFN-beta or glatiramer acetate in relapsing MS

Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Shibeshih Belachew, Robert Hyde, Freek Verheul, Alessandra Lugaresi, Eva Havrdova, Dana Horakova, Pierre Grammond, Pierre Duquette, Alexandre Prat, Gerardo Iuliano, Murat Terzi, Guillermo Izquierdo, Raymond MM Hupperts, Cavit Boz, et al.

Journal article  |  2016  |  Neurology: Clinical Practice

Defining reliable disability outcomes in multiple sclerosis

Tomas Kalincik, Gary Cutter, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Raymond Hupperts, Celia Oreja-Guevara, Cavit Boz, Eugenio Pucci, Roberto Bergamaschi, Jeannette Lechner-Scott, et al.

Journal article  |  2015  |  BRAIN

Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis (vol 72, pg 405, 2015)

A He, T Spelman, V Jokubaitis

Journal article  |  2015  |  JAMA Neurology

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Pierre Grammond, Alessandra Lugaresi, Celia Oreja-Guevara, Roberto Bergamaschi, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Vincent Van Pesch, Cavit Boz, Gerardo Iuliano, Ricardo Fernandez-Bolanos, Shlomo Flechter, Daniele Spitaleri, Edgardo Cristiano, Freek Verheul, et al.

Journal article  |  2015  |  MULTIPLE SCLEROSIS JOURNAL

Galanin is an Autocrine Myelin and Oligodendrocyte Trophic Signal Induced by Leukemia Inhibitory Factor

Melissa M Gresle, Helmut Butzkueven, Victoria M Perreau, Anna Jonas, Junhua Xiao, Stefan Thiem, Fiona E Holmes, William Doherty, Pik-Ying Soo, Michele D Binder, Rainer Akkermann, Vilija G Jokubaitis, Holly S Cate, Mark P Marriott, Andrew L Gundlach, David Wynick, Trevor J Kilpatrick

Journal article  |  2015  |  Glia

Predictors of disability worsening in clinically isolated syndrome

Vilija G Jokubaitis, Tim Spelman, Tomas Kalincik, Guillermo Izquierdo, Francois Grand'Maison, Pierre Duquette, Marc Girard, Alessandra Lugaresi, Pierre Grammond, Raymond Hupperts, Jose Cabrera-Gomez, Celia Oreja-Guevara, Cavit Boz, Giorgio Giuliani, Ricardo Fernandez-Bolanos, Gerardo Iuliano, Jeannette Lechner-Scott, Freek Verheul, Vincent van Pesch, Tatjana Petkovska-Boskova, et al.

Journal article  |  2015  |  ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis

Anna He, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Marc Girard, Eugenio Pucci, Gerardo Iuliano, Raed Alroughani, Celia Oreja-Guevara, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Patrizia Sola, Daniele Spitaleri, Franco Granella, et al.

Journal article  |  2015  |  JAMA NEUROLOGY

Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis

Tomas Kalincik, Dana Horakova, Tim Spelman, Vilija Jokubaitis, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Csilla Rozsa, Pierre Grammond, Raed Alroughani, Pierre Duquette, Marc Girard, Eugenio Pucci, Jeannette Lechner-Scott, Mark Slee, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Raymond Hupperts, Freek Verheul, Suzanne Hodgkinson, et al.

Journal article  |  2015  |  ANNALS OF NEUROLOGY

Erratum: Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis (JAMA Neurology (2015) 72:4 (405-413))

A He, T Spelman, V Jokubaitis

Journal article  |  2015  |  JAMA Neurology

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

JI Rojas, L Patrucco, M Trojano, A Lugaresi, G Izquierdo, H Butzkueven, V Jokubaitis, P Duquette, M Girard, F Grand'Maison, P Grammond, C Oreja-Guevara, R Hupperts, C Boz, T Petersen, R Bergamaschi, G Giuliani, J Lechner-Scott, M Barnett, ME Rio, et al.

Journal article  |  2015  |  Multiple Sclerosis Journal: Experimental, Translational and Clinical

Limited data suggest that multiple sclerosis (MS) in Latin America (LA) could be less severe than in the rest of the world. The ob..

Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation

Anna Jonas, Stefan Thiem, Tanja Kuhlmann, Raimund Wagener, Attila Aszodi, Cameron Nowell, Mann Hagemeier, Louise Laverick, Victoria Perreau, Vilija Jokubaitis, Ben Emery, Trevor Kilpatrick, Helmut Butzkueven, Melissa Gresle

Journal article  |  2014  |  JOURNAL OF CLINICAL INVESTIGATION

Risk of relapse phenotype recurrence in multiple sclerosis

Tomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Marc Girard, Alessandra Lugaresi, Pierre Grammond, Francois Grand'Maison, Celia Oreja-Guevara, Cavit Boz, Raymond Hupperts, Thor Petersen, Giorgio Giuliani, Gerardo Iuliano, Jeannette Lechner-Scott, Michael Barnett, Roberto Bergamaschi, Vincent Van Pesch, et al.

Journal article  |  2014  |  MULTIPLE SCLEROSIS JOURNAL

Ceruloplasmin gene-deficient mice with experimental autoimmune encephalomyelitis show attenuated early disease evolution

Melissa M Gresle, Katrin Schulz, Anna Jonas, Victoria M Perreau, Tania Cipriani, Alan G Baxter, Socorro Miranda-Hernandez, Judith Field, Vilija G Jokubaitis, Robert Cherny, Irene Volitakis, Samuel David, Trevor J Kilpatrick, Helmut Butzkueven

Journal article  |  2014  |  JOURNAL OF NEUROSCIENCE RESEARCH

Fingolimod after natalizumab and the risk of short-term relapse

Vilija G Jokubaitis, Vivien Li, Tomas Kalincik, Guillermo Izquierdo, Suzanne Hodgkinson, Raed Alroughani, Jeannette Lechner-Scott, Alessandra Lugaresi, Pierre Duquette, Marc Girard, Michael Barnett, Francois Grand'Maison, Maria Trojano, Mark Slee, Giorgio Giuliani, Cameron Shaw, Cavit Boz, Daniele LA Spitaleri, Freek Verheul, Jodi Haartsen, et al.

Journal article  |  2014  |  NEUROLOGY

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomas Kalincik, Vino Vivek, Vilija Jokubaitis, Jeannette Lechner-Scott, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Francois Grand'Maison, Raymond Hupperts, Celia Oreja-Guevara, Roberto Bergamaschi, Gerardo Iuliano, Raed Alroughani, Vincent Van Pesch, Maria Pia Amato, Mark Slee, Freek Verheul, Ricardo Fernandez-Bolanos, Marcela Fiol, Daniele La Spitaleri, et al.

Journal article  |  2013  |  BRAIN

Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?

VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, J Lechner-Scott, A Lugaresi, P Duquette, M Girard, M Barnett, F Grand'Maison, M Trojano, M Slee, G Giuliani, C Shaw, C Boz, J Haartsen, D Liew, H Butzkueven

Conference Proceedings  |  2013  |  MULTIPLE SCLEROSIS JOURNAL

The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform

Vilija G Jokubaitis, Tim Spelman, Jeannette Lechner-Scott, Michael Barnett, Cameron Shaw, Steve Vucic, Danny Liew, Helmut Butzkueven, Mark Slee

Journal article  |  2013  |  PLOS ONE

Predictors of 12 Month Confirmed Disability Progression after Onset of Clinically Isolated Syndrome (CIS) Suggestive of Multiple Sclerosis

Helmut Butzkueven, Vilija Jokubaitis, Tim Spelman

Conference Proceedings  |  2013  |  NEUROLOGY

Microglial Function in MS Pathology

Trevor J Kilpatrick, Vilija G Jokubaitis

Book Chapter  |  2013

Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis

Vilija G Jokubaitis, Melissa M Gresle, Dennis A Kemper, William Doherty, Victoria M Perreau, Tania L Cipriani, Anna Jonas, Gerry Shaw, Tanja Kuhlmann, Trevor J Kilpatrick, Helmut Butzkueven

Journal article  |  2013  |  ACTA NEUROPATHOLOGICA COMMUNICATIONS

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.

Tomas Kalincik, Timothy Spelman, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, Alessandra Lugaresi, Raymond Hupperts, Edgardo Cristiano, Vincent Van Pesch, Francois Grand'maison, Daniele La Spitaleri, Maria Edite Rio, Sholmo Flechter, Celia Oreja-Guevara, Giorgio Giuliani, Aldo Savino, Maria Pia Amato, Thor Petersen, Ricardo Fernandez-Bolanos, et al.

Journal article  |  2013  |  PLoS One

OBJECTIVES: To compare treatment persistence between two dosages of interferon β-1a in a large observational multiple sclerosis re..

Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

Maria Trojano, Guglielmo Lucchese, Giusi Graziano, Bruce V Taylor, Steve Simpson, Vito Lepore, Francois Grand'Maison, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, Maria Pia Amato, Roberto Bergamaschi, Giorgio Giuliani, Cavit Boz, Raymond Hupperts, Vincent Van Pesch, Jeannette Lechner-Scott, Edgardo Cristiano, Marcela Fiol, Celia Oreja-Guevara, et al.

Journal article  |  2012  |  PLOS ONE

Leukemia Inhibitory Factor Protects Axons in Experimental Autoimmune Encephalomyelitis via an Oligodendrocyte-Independent Mechanism

Melissa M Gresle, Estella Alexandrou, Qizhu Wu, Gary Egan, Vilija Jokubaitis, Margaret Ayers, Anna Jonas, William Doherty, Anna Friedhuber, Gerry Shaw, Michael Sendtner, Ben Emery, Trevor Kilpatrick, Helmut Butzkueven

Journal article  |  2012  |  PLOS ONE

Increasing age at disability milestones among MS patients in the MSBase Registry

Ilya Kister, Eric Chamot, Gary Cutter, Tamar E Bacon, Vilija G Jokubaitis, Stella E Hughes, Orla M Gray, Maria Trojano, Guillermo Izquierdo, Francois Grand'Maison, Pierre Duquette, Alessandra Lugaresi, Pierre Grammond, Cavit Boz, Raymond Hupperts, Thor Petersen, Giorgio Giuliani, Celia Oreja-Guevara, Gerardo Iuliano, Jeannette Lechner-Scott, et al.

Journal article  |  2012  |  Journal of the Neurological Sciences

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

J Lechner-Scott, B Spencer, T de Malmanche, J Attia, M Fitzgerald, M Trojano, F Grand'Maison, J Antonio C Gomez, G Izquierdo, P Duquette, M Girard, P Grammond, C Oreja-Guevara, R Hupperts, R Bergamaschi, C Boz, G Giuliani, V van Pesch, G Iuliano, M Fiol, et al.

Journal article  |  2012  |  Multiple Sclerosis

Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome

Claire Meyniel, Timothy Spelman, Vilija G Jokubaitis, Maria Trojano, Guillermo Izquierdo, Francois Grand'Maison, Celia Oreja-Guevara, Cavit Boz, Alessandra Lugaresi, Marc Girard, Pierre Grammond, Gerardo Iuliano, Marcela Fiol, Jose Antonio Cabrera-Gomez, Ricardo Fernandez-Bolanos, Giorgio Giuliani, Jeannette Lechner-Scott, Edgardo Cristiano, Joseph Herbert, Tatjana Petkovska-Boskova, et al.

Journal article  |  2012  |  PLOS ONE

Predictors of time to first confirmed disability progression after clinically isolated syndrome onset: an MSBase study

VG Jokubaitis, T Spelman, C Meyniel, M Trojano, G Izquierdo, F Grand'Maison, C Zwanikken, C Oreja-Guevara, M Tanner, M Rutherford, H Butzkueven

Conference Proceedings  |  2012  |  MULTIPLE SCLEROSIS JOURNAL

Endogenous leukaemia inhibitory factor signalling reduces axonal damage in mice with EAE

MM Gresle, E Alexandrou, B Wang, G Egan, M Ayres, V Jokubaitis, A Jonas, AM Friedhuber, W Doherty, A Achuthan, G Shaw, J Vacher, M Sendtner, TJ Kilpatrick, H Butzkueven

Conference Proceedings  |  2012  |  MULTIPLE SCLEROSIS JOURNAL

Treatment persistence in the Australian relapsing remitting MS population: Results from the MSBase Registry

VG Jokubaitis, H Butzkueven, T Spelman, J Lechner-Scott, M Barnett, C Shaw, S Vucic, M Slee

Conference Proceedings  |  2012  |  MULTIPLE SCLEROSIS JOURNAL

Predictors of Time to First Disability Progression after CIS: An MSBase Substudy

Helmut Butzkueven, Tim Spelman, Vilija Jokubaitis, Michelle Rutherford, Mary Tanner

Conference Proceedings  |  2012  |  NEUROLOGY

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

Stella Hughes, Timothy Spelman, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Pierre Duquette, Marc Girard, Pierre Grammond, Celia Oreja-Guevara, Raymond Hupperts, Cavit Boz, Roberto Bergamaschi, Giorgio Giuliani, Maria Edite Rio, Jeannette Lechner-Scott, Vincent van Pesch, Gerardo Iuliano, Marcela Fiol, Freek Verheul, et al.

Journal article  |  2012  |  Journal of Neurology, Neurosurgery and Psychiatry

Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination

Michele D Binder, Holly S Cate, Anne L Prieto, Dennis Kemper, Helmut Butzkueven, Melissa M Gresle, Tania Cipriani, Vilija G Jokubaitis, Peter Carmeliet, Trevor J Kilpatrick

Journal article  |  2008  |  JOURNAL OF NEUROSCIENCE